Login

    Log In to SINEORA
    Login with your social media account
    or
    Use your corporate e-mail address
    Forgot your password?
    New to SINEORA?
    Find the best technology startups for your innovation or join our startup program. Create an account

    register

    Sign Up: Create your company account

    By sign up you get the following benefits:

    • Select best local partner to continuously enrich our pipeline
    • Pre-screening relevant ones
    • Pre-screening the startups in our focused domain, namely AI, Industrial IoT, B2B software, Robotics and Blockchain
    • Startups Assessment Report (360-degree view with our originally developed methodology)
    • Deep understanding of corporates’ digital transformation challenges and constraints
    • Focusing on synergized scenario
    • Fine tune process empowered by our algorithm (per initiative)

    Select the better description for your innovation company

    corporation

    Corporate
    Looking to find inspiration about technology trends to be used in my company and to find the right startup to hire.

    Select
    startup

    Startup
    My company is offering a new and exciting technology and we want to have better exposure.

    Select

    If you already have an account,

    corporate form

    startup form

    Startup Search Results / GenSight Biologics
    GenSight Biologics

    GenSight Biologics

    Develops innovative therapies for mitochondrial and neurodegenerative diseases

    gensight-biologics.com
    Paris France (HQ)
    36 employees
    Launch date : 2013
    linkedin
    Request report Save
    Business Domains:
    B2B manufacturing health biotechnology
    Technologies:
    biotechnology health care medical genetics neurology
    Date Investor Amount
    - IBionextAgoranov
    N/A
    Apr 2013 Index VenturesNovartis Venture FundAbingworth LLPVersant Ventures SERIES A
    €32m
    Jul 2015 Index VenturesNovartis Venture FundAbingworth LLPHealthCapFidelityJennison AssociatesVersant VenturesPerceptive Advisors SERIES B
    $36m
    Jul 2016 N/A IPO*
    €45.3m
    Jul 2017* N/A POST IPO EQUITY
    €22.5m
    Feb 2019 Sofinnova Partners GROWTH EQUITY
    $9.1m
    Dec 2019 Kreos CapitalSofinnova Partners3SBio POST IPO DEBT
    $16.6m
    Investor Amount
    Abingworth LLP SERIES B, SERIES A
    Novartis Venture Fund SERIES B, SERIES A
    Index Ventures SERIES B, SERIES A
    HealthCap SERIES B
    Fidelity SERIES B
    Jennison Associates SERIES B
    Perceptive Advisors SERIES B
    Versant Ventures SERIES B, SERIES A
    Sofinnova Partners POST IPO DEBT, GROWTH EQUITY
    3SBio POST IPO DEBT
    Kreos Capital POST IPO DEBT
    IBionext
    Agoranov
    Startup Assessment Reports
    Help you with 360-degree information about Startups and their solutions. Request report

    RECENT NEWS

    INTERACT WITH THIS STARTUP